BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:XS-04 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of XS-04\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06820268-2954@assetmemo.bio
DTSTAMP:20261121T005921Z
DTSTART;VALUE=DATE:20271101
DTEND;VALUE=DATE:20271102
SUMMARY:XS-04: Phase 1 readout est. (NCT06820268)
DESCRIPTION:XS-04\, phase 1\, Acute Myeloid Leukemia.\nStudy: A Study of XS
 -04 in Patients With Relapsed or Refractory Hematologic Malignancies\nEsti
 mated primary completion: 1 November 2027. This is a ClinicalTrials.gov es
 timate\, not a confirmed readout date\, and it can move.\nDrug page: https
 ://assetmemo.bio/drug/xs-04#upcoming-events\nRegistry record: https://clin
 icaltrials.gov/study/NCT06820268
URL:https://assetmemo.bio/drug/xs-04#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
